| Identification | Back Directory |  [Name]
  dendrophenol |  [CAS]
  108853-14-1 |  [Synonyms]
  Aloifol II Moscatilin dendrophenol Gigantol(Dendrophenol) 4,4'-Dihydroxy-3,3',5-trimethoxybibenzyl 4-(4-hydroxy-3-methoxyphenethyl)-2,6-dimethoxyphenol 4-[2-(4-Hydroxy-3-methoxyphenyl)ethyl]-2,6-dimethoxy-phenol Phenol,4-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-2,6-dimethoxy- |  [EINECS(EC#)]
  300-009-3 |  [Molecular Formula]
  C17H20O5 |  [MOL File]
  108853-14-1.mol |  [Molecular Weight]
  304.338 |  
 | Chemical Properties | Back Directory |  [Melting point ]
  87-89℃ (ethyl ether ) |  [Boiling point ]
  454.1±40.0 °C |  [density ]
  1.208±0.06 g/cm3 (20 ºC 760 Torr) |  [storage temp. ]
  Store at -20°C |  [solubility ]
  Soluble in DMSO |  [form ]
  Solid |  [pka]
  10.09±0.20(Predicted) |  [color ]
  White to off-white |  [InChI]
  InChI=1S/C17H20O5/c1-20-14-8-11(6-7-13(14)18)4-5-12-9-15(21-2)17(19)16(10-12)22-3/h6-10,18-19H,4-5H2,1-3H3 |  [InChIKey]
  YTRAYUIKLRABOQ-UHFFFAOYSA-N |  [SMILES]
  C1(O)=C(OC)C=C(CCC2=CC=C(O)C(OC)=C2)C=C1OC |  
 | Hazard Information | Back Directory |  [Uses]
  Dendrophenol can be used to protect against high glucose-evoked nephrotoxicity in vivo. It can be used with HPLC-PDA-HRMS-SPE-NMR for determination of its inhibitive activities. |  [in vivo]
 
 Dendrophenol (10 mg/kg; intraperitoneal injection; 3 weeks) has a beneficial effect in the mouse model of vascular calcification[3].  
Dendrophenol (50-100 mg/kg; intraperitoneal injection; 5 times a week for 2 weeks) has antitumor effect in mouse tumor model[4]. | Animal Model: | Nicotine and Vitamin D3 (HY-15398) treated male C57BL/6J mice aged 25 weeks old[3] |  | Dosage: | 10 mg/kg |  | Administration: | Intraperitoneal injection (i.p.); 3 weeks |  | Result: | Reduced calcium accumulation in the thoracic aorta and aortic valves of the mice.  
Reduced the expression of calcification-related genes, such as ALPL, BMP2 and RUNX2.
 |  
 | Animal Model: | HCT-116 cells treated male severe combined immunodeficient mice[4] |  | Dosage: | 50 and 100 mg/kg |  | Administration: | Intraperitoneal injection (i.p.); five times a week for two weeks |  | Result: | Significantly inhibited tumor growth and did not result in weight loss.
 |  
 
  |  [IC 50]
  NF-κB; COX-2; HIF-1α |  
  
             | 
            
            
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
             |